TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT06028074: Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies

Sponsor: Georgiamune Inc · Phase: PHASE1/PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 111 pts

Competing Trials Overlap

8 Active Trials

Excess Burn Exposure

$1,241,680

Rescue Site Savings

+$818,380

Unlock Full NCT06028074 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06028074 Rescue Dossier →